CAeditome Logo

Home

Download

Statistics

Landscape

Help

Contact
Center for Computational Systems Medicine
Soverview

1. Gene summary of enriched editing regions

Soverview

2. Tumor-specific enriched editing regions

Comparison of enriched editing regions between tumor and normal.

Correlation of enriched editing regions with tumor stages.

Associations of enriched editing regions with cancer survival.

Soverview

3. Enriched editing regions and immune related genes

Soverview

4. Enriched editing regions and immune related splicing

Soverview

5. Enriched editing regions and immune infiltration

Soverview

6. Enriched editing regions and immune gene sets

Correlation of enriched editing regions with epithelial-mesenchymal transition.

Correlations of enriched editing regions with hypoxic.

Associations of enriched editing regions with hallmark gene sets from MSigDB.

Soverview

7. Enriched editing regions and drugs

Correlations between enriched editing regions and drug sensitivity.

Enriched editing regions targeted by drugs from DrugBank database.

Editing gene: CSAD (ImmuneEditome ID:51380)

1. Gene summary of enriched editing regions for CSAD

check button Gene summary
Gene informationGene symbol

CSAD

Gene ID

51380

GeneSynonymsCSD|PCAP
GeneCytomap

12q13.13

GeneTypeprotein-coding
GeneDescriptioncysteine sulfinic acid decarboxylase|P-selectin cytoplasmic tail-associated protein|aspartate 1-decarboxylase|cysteine sulfinic acid decarboxylase-related protein|cysteine-sulfinate decarboxylase|sulfinoalanine decarboxylase
GeneModificationdate20230517
UniprotIDA0A024RAX7;Q9Y600;Q9Y602;C9JTU8;H3BTP4;F8VV11;H3BQ59;F8WCW3;E9PFW9
PubMed ID

check buttonUCSC image.
all structure

check buttonLocations of each EERs.
EERENSTENSGGeneNameRegionRepeatdsRNA structure
chr12:53174012-53174827:-ENST00000267085.7ENSG00000139631.17CSADintronicAluSx1,AluY,L1MB7,L1ME4achr12:53174012-53174827:-.alignment
chr12:53174012-53174827:-ENST00000379846.4ENSG00000139631.17CSADintronicAluSx1,AluY,L1MB7,L1ME4achr12:53174012-53174827:-.alignment
chr12:53174012-53174827:-ENST00000379850.6ENSG00000139631.17CSADintronicAluSx1,AluY,L1MB7,L1ME4achr12:53174012-53174827:-.alignment
chr12:53174012-53174827:-ENST00000424990.4ENSG00000139631.17CSADintronicAluSx1,AluY,L1MB7,L1ME4achr12:53174012-53174827:-.alignment
chr12:53174012-53174827:-ENST00000437073.4ENSG00000139631.17CSADintronicAluSx1,AluY,L1MB7,L1ME4achr12:53174012-53174827:-.alignment
chr12:53174012-53174827:-ENST00000444623.4ENSG00000139631.17CSADintronicAluSx1,AluY,L1MB7,L1ME4achr12:53174012-53174827:-.alignment
chr12:53174012-53174827:-ENST00000453446.5ENSG00000139631.17CSADintronicAluSx1,AluY,L1MB7,L1ME4achr12:53174012-53174827:-.alignment
chr12:53176125-53179181:-ENST00000379846.4ENSG00000139631.17CSADsplicingAluJb,AluJr,L1ME3G,L1ME4b,AluSq2,FLAM_A,(TATT)n,AluSp,AluSx1,AluYchr12:53176125-53179181:-.alignment
chr12:53176125-53179181:-ENST00000444623.4ENSG00000139631.17CSADsplicingAluJb,AluJr,L1ME3G,L1ME4b,AluSq2,FLAM_A,(TATT)n,AluSp,AluSx1,AluYchr12:53176125-53179181:-.alignment


Top

2. Tumor-specific enriched editing regions for CSAD


all structure

check buttonComparison of enriched editing regions between tumor and normal.
* P<0.05 and Informative number >=20.
* EER: enriched editing region, EAG: EER-associated genes.
ID_eventscancerTypePBoxplot
chr12:53174012-53174827:-BRCAEER5.1874e-05image
ENSG00000139631.17,CSADBRCAEAG4.4001e-02image


Top

check buttonCorrelation of enriched editing regions with tumor stages.
* AnovaP<0.05, Pearson P<0.05 and Informative number >=20.
* EER: enriched editing region, EAG: EER-associated genes, Path: Pathological stage, Cli: Clinical stage.
* Only shows the most significant correlation result of EERs/EAGs with either pathological stage or clinical stage according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerTypeStageTypeAnovaPPRBoxplot
chr12:53176125-53179181:-PAADPathEER1.9712e-022.7597e-020.3214image
ENSG00000139631.17,CSADPAADPathEAG1.4242e-048.1970e-030.2974image


Top

check button Associations of enriched editing regions with cancer survival.
* Pkm<0.05 and Pcox<0.05.
* EER: enriched editing region, EAG: EER-associated genes.
ID_eventscancerTypeIDPkmPcox_continuousHR_continuousKMPlot

Top

3. Enriched editing regions and immune related genes for CSAD


all structure

check button Enriched editing regions and immune related genes.
* First, the associations between enriched editing regions and genes were tested by QTL and Pearson method (QTL: FDR<0.05 and Pearson: P<0.05).
* Second, the gene relationships with immune were tested by three analyses: whether the gene is an immune gene (InnateDB、Immport、Immunome、Immunogenetic Related Information Source (IRIS)), whether the gene is associated with immune infiltration and whether the gene is related to immune gene sets.
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of genes with the fraction of different immune cells and the scores of 50 hallmark genesets according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerTypeGenebetaFDRPearsonPPearsonRCorrelationPlotRBPRBPtargetsImmuneGeneImmuneFractionHallMark
chr12:53174012-53174827:-OVEERENSG00000156411,C14orf20.31225.0858e-045.6251e-100.4104imageNNNANK_cells_activatedGSVA_HALLMARK_OXIDATIVE_PHOSPHORYLATION
chr12:53174012-53174827:-OVEERENSG00000129562,DAD10.28062.3663e-031.3548e-140.4975imageNNDAD1T_cells_CD8GSVA_HALLMARK_OXIDATIVE_PHOSPHORYLATION
chr12:53174012-53174827:-OVEERENSG00000179933,C14orf1190.23881.3030e-024.4848e-110.4334imageNNNAMacrophages_M0GSVA_HALLMARK_OXIDATIVE_PHOSPHORYLATION
chr12:53174012-53174827:-OVEERENSG00000100804,PSMB50.21632.8724e-021.5976e-130.4794imageNNPSMB5Plasma_cellsGSVA_HALLMARK_DNA_REPAIR
chr12:53174012-53174827:-OVEERENSG00000172590,MRPL520.20074.5827e-025.7907e-130.4695imageNNNAT_cells_CD8GSVA_HALLMARK_UV_RESPONSE_DN
chr12:53174012-53174827:-THYMEERENSG00000100711,ZFYVE210.31482.4064e-024.5551e-050.4203imageNNNAT_cells_regulatory_(Tregs)GSVA_HALLMARK_ESTROGEN_RESPONSE_LATE
chr12:53174012-53174827:-OVEERENSG00000156411,C14orf20.31225.0858e-045.6251e-100.4104imageNNNANK_cells_activatedGSVA_HALLMARK_OXIDATIVE_PHOSPHORYLATION
chr12:53174012-53174827:-OVEERENSG00000129562,DAD10.28062.3663e-031.3548e-140.4975imageNNDAD1T_cells_CD8GSVA_HALLMARK_OXIDATIVE_PHOSPHORYLATION
chr12:53174012-53174827:-OVEERENSG00000179933,C14orf1190.23881.3030e-024.4848e-110.4334imageNNNAMacrophages_M0GSVA_HALLMARK_OXIDATIVE_PHOSPHORYLATION
chr12:53174012-53174827:-OVEERENSG00000100804,PSMB50.21632.8724e-021.5976e-130.4794imageNNPSMB5Plasma_cellsGSVA_HALLMARK_DNA_REPAIR
chr12:53174012-53174827:-OVEERENSG00000172590,MRPL520.20074.5827e-025.7907e-130.4695imageNNNAT_cells_CD8GSVA_HALLMARK_UV_RESPONSE_DN
chr12:53174012-53174827:-THYMEERENSG00000100711,ZFYVE210.31482.4064e-024.5551e-050.4203imageNNNAT_cells_regulatory_(Tregs)GSVA_HALLMARK_ESTROGEN_RESPONSE_LATE
chr12:53174012-53174827:-OVEERENSG00000156411,C14orf20.31225.0858e-045.6251e-100.4104imageNNNANK_cells_activatedGSVA_HALLMARK_OXIDATIVE_PHOSPHORYLATION
chr12:53174012-53174827:-OVEERENSG00000129562,DAD10.28062.3663e-031.3548e-140.4975imageNNDAD1T_cells_CD8GSVA_HALLMARK_OXIDATIVE_PHOSPHORYLATION
chr12:53174012-53174827:-OVEERENSG00000179933,C14orf1190.23881.3030e-024.4848e-110.4334imageNNNAMacrophages_M0GSVA_HALLMARK_OXIDATIVE_PHOSPHORYLATION
chr12:53174012-53174827:-OVEERENSG00000100804,PSMB50.21632.8724e-021.5976e-130.4794imageNNPSMB5Plasma_cellsGSVA_HALLMARK_DNA_REPAIR
chr12:53174012-53174827:-OVEERENSG00000172590,MRPL520.20074.5827e-025.7907e-130.4695imageNNNAT_cells_CD8GSVA_HALLMARK_UV_RESPONSE_DN
chr12:53174012-53174827:-THYMEERENSG00000100711,ZFYVE210.31482.4064e-024.5551e-050.4203imageNNNAT_cells_regulatory_(Tregs)GSVA_HALLMARK_ESTROGEN_RESPONSE_LATE
chr12:53174012-53174827:-OVEERENSG00000156411,C14orf20.31225.0858e-045.6251e-100.4104imageNNNANK_cells_activatedGSVA_HALLMARK_OXIDATIVE_PHOSPHORYLATION
chr12:53174012-53174827:-OVEERENSG00000129562,DAD10.28062.3663e-031.3548e-140.4975imageNNDAD1T_cells_CD8GSVA_HALLMARK_OXIDATIVE_PHOSPHORYLATION
chr12:53174012-53174827:-OVEERENSG00000179933,C14orf1190.23881.3030e-024.4848e-110.4334imageNNNAMacrophages_M0GSVA_HALLMARK_OXIDATIVE_PHOSPHORYLATION
chr12:53174012-53174827:-OVEERENSG00000100804,PSMB50.21632.8724e-021.5976e-130.4794imageNNPSMB5Plasma_cellsGSVA_HALLMARK_DNA_REPAIR
chr12:53174012-53174827:-OVEERENSG00000172590,MRPL520.20074.5827e-025.7907e-130.4695imageNNNAT_cells_CD8GSVA_HALLMARK_UV_RESPONSE_DN
chr12:53174012-53174827:-THYMEERENSG00000100711,ZFYVE210.31482.4064e-024.5551e-050.4203imageNNNAT_cells_regulatory_(Tregs)GSVA_HALLMARK_ESTROGEN_RESPONSE_LATE
chr12:53174012-53174827:-OVEERENSG00000156411,C14orf20.31225.0858e-045.6251e-100.4104imageNNNANK_cells_activatedGSVA_HALLMARK_OXIDATIVE_PHOSPHORYLATION
chr12:53174012-53174827:-OVEERENSG00000129562,DAD10.28062.3663e-031.3548e-140.4975imageNNDAD1T_cells_CD8GSVA_HALLMARK_OXIDATIVE_PHOSPHORYLATION
chr12:53174012-53174827:-OVEERENSG00000179933,C14orf1190.23881.3030e-024.4848e-110.4334imageNNNAMacrophages_M0GSVA_HALLMARK_OXIDATIVE_PHOSPHORYLATION
chr12:53174012-53174827:-OVEERENSG00000100804,PSMB50.21632.8724e-021.5976e-130.4794imageNNPSMB5Plasma_cellsGSVA_HALLMARK_DNA_REPAIR
chr12:53174012-53174827:-OVEERENSG00000172590,MRPL520.20074.5827e-025.7907e-130.4695imageNNNAT_cells_CD8GSVA_HALLMARK_UV_RESPONSE_DN
chr12:53174012-53174827:-THYMEERENSG00000100711,ZFYVE210.31482.4064e-024.5551e-050.4203imageNNNAT_cells_regulatory_(Tregs)GSVA_HALLMARK_ESTROGEN_RESPONSE_LATE
chr12:53174012-53174827:-OVEERENSG00000156411,C14orf20.31225.0858e-045.6251e-100.4104imageNNNANK_cells_activatedGSVA_HALLMARK_OXIDATIVE_PHOSPHORYLATION
chr12:53174012-53174827:-OVEERENSG00000129562,DAD10.28062.3663e-031.3548e-140.4975imageNNDAD1T_cells_CD8GSVA_HALLMARK_OXIDATIVE_PHOSPHORYLATION
chr12:53174012-53174827:-OVEERENSG00000179933,C14orf1190.23881.3030e-024.4848e-110.4334imageNNNAMacrophages_M0GSVA_HALLMARK_OXIDATIVE_PHOSPHORYLATION
chr12:53174012-53174827:-OVEERENSG00000100804,PSMB50.21632.8724e-021.5976e-130.4794imageNNPSMB5Plasma_cellsGSVA_HALLMARK_DNA_REPAIR
chr12:53174012-53174827:-OVEERENSG00000172590,MRPL520.20074.5827e-025.7907e-130.4695imageNNNAT_cells_CD8GSVA_HALLMARK_UV_RESPONSE_DN
chr12:53174012-53174827:-THYMEERENSG00000100711,ZFYVE210.31482.4064e-024.5551e-050.4203imageNNNAT_cells_regulatory_(Tregs)GSVA_HALLMARK_ESTROGEN_RESPONSE_LATE
chr12:53174012-53174827:-OVEERENSG00000156411,C14orf20.31225.0858e-045.6251e-100.4104imageNNNANK_cells_activatedGSVA_HALLMARK_OXIDATIVE_PHOSPHORYLATION
chr12:53174012-53174827:-OVEERENSG00000129562,DAD10.28062.3663e-031.3548e-140.4975imageNNDAD1T_cells_CD8GSVA_HALLMARK_OXIDATIVE_PHOSPHORYLATION
chr12:53174012-53174827:-OVEERENSG00000179933,C14orf1190.23881.3030e-024.4848e-110.4334imageNNNAMacrophages_M0GSVA_HALLMARK_OXIDATIVE_PHOSPHORYLATION
chr12:53174012-53174827:-OVEERENSG00000100804,PSMB50.21632.8724e-021.5976e-130.4794imageNNPSMB5Plasma_cellsGSVA_HALLMARK_DNA_REPAIR
chr12:53174012-53174827:-OVEERENSG00000172590,MRPL520.20074.5827e-025.7907e-130.4695imageNNNAT_cells_CD8GSVA_HALLMARK_UV_RESPONSE_DN
chr12:53174012-53174827:-THYMEERENSG00000100711,ZFYVE210.31482.4064e-024.5551e-050.4203imageNNNAT_cells_regulatory_(Tregs)GSVA_HALLMARK_ESTROGEN_RESPONSE_LATE

More results



Top

4. Enriched editing regions and immune related splicing for CSAD


all structure

check button Enriched editing regions and immune related splicing.
* First, the associations between enriched editing regions and splicing events were tested by QTL and Pearson method (QTL: FDR<0.05 and Pearson: P<0.05).
* Second, the splicing relationships with immune were tested by three analyses: whether the splicing event locates in an immune gene (InnateDB、Immport, Immunome and Immunogenetic Related Information Source (IRIS)), whether the splicing event is associated with immune infiltration and whether the splicing event is related to immune gene sets.
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of splicing events with the fraction of different immune cells and the scores of 50 hallmark genesets according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerTypeSplicingTypeSplicingGeneSplicingChrSplicingPositionbetaFDRPearsonPPearsonRCorrelationPlotRBPRBPtargetsImmuneGeneImmuneFractionHallMark
chr12:53174012-53174827:-
OVEERA5ENSG00000170144.14chr2177216907:177216940:177216675:177216735:177216675:1772167470.06372.2652e-021.5841e-080.4048imageNNNAPlasma_cells
chr12:53174012-53174827:-
OVEERMEXENSG00000081665.9chr1919786561:19786854:19789616:19789647:19791561:19792484:19806030:198061260.14574.7121e-029.4475e-080.4044imageNNNAPlasma_cellsGSVA_HALLMARK_TGF_BETA_SIGNALING
ENSG00000139631.17,CSAD
THYMEAGIRENSG00000102890.10chr1667202626:67203004:67203118:67203223-0.40581.4718e-025.7982e-05-0.4173imageNADAR;AIFM1;AUH;BCCIP;BUD13;CPSF6;CSTF2T;DDX42;DDX54;DGCR8;DICER1;EIF4A3;EIF4G2;EWSR1;FAM120A;FBL;FMR1;FUS;FXR1;FXR2;GTF2F1;HNRNPA1;HNRNPA2B1;HNRNPC;HNRNPK;HNRNPL;HNRNPM;HNRNPU;HNRNPUL1;IGF2BP2;IGF2BP3;LARP7;LIN28B;LSM11;NOP58;NPM1;PCBP2;PRPF8;PTBP1;RANGAP1;RBFOX2;RBM10;RBM22;RBM27;SF3A3;SF3B4;SLTM;SMNDC1;SND1;SRSF1;SRSF7;SRSF9;TAF15;TARDBP;TIA1;TNRC6A;TRA2A;TROVE2;U2AF1;U2AF2;XRN2;ZNF184ELMO3T_cells_CD4_naiveGSVA_HALLMARK_E2F_TARGETS
ENSG00000139631.17,CSAD
THYMEAGMEXENSG00000119013.4chr2201072029:201072059:201072338:201072361:201073070:201073153:201078880:2010790220.38522.1185e-027.3580e-050.4165imageNAIFM1;AUH;BUD13;CNBP;CPSF6;CSTF2T;DDX3X;DDX42;DDX54;DGCR8;DHX9;EIF4A3;EIF4G2;ELAVL1;ELAVL3;EWSR1;FAM120A;FBL;FMR1;FUS;FXR1;FXR2;GNL3;GTF2F1;HNRNPA1;HNRNPA2B1;HNRNPC;HNRNPU;HNRNPUL1;IGF2BP1;IGF2BP2;IGF2BP3;KHDRBS1;KHDRBS2;KHSRP;LARP7;LIN28;LIN28B;LSM11;MOV10;MSI2;NONO;NOP56;NOP58;NUMA1;PRPF8;PTBP1;RBFOX2;RBM10;RBM27;SAFB2;SBDS;SLTM;SMNDC1;SND1;SRSF1;SRSF3;SRSF7;SRSF9;TAF15;TARDBP;TIA1;TIAL1;TNRC6A;TRA2A;TROVE2;U2AF1;U2AF2;UPF1;XRN2;YWHAG;ZNF184NA
ENSG00000139631.17,CSAD
THYMEAGMEXENSG00000119013.4chr2201072029:201072059:201072278:201072361:201073070:201073153:201078880:2010790220.38162.8046e-026.4475e-050.4172imageNAIFM1;AUH;BUD13;CNBP;CPSF6;CSTF2T;DDX3X;DDX42;DDX54;DGCR8;DHX9;EIF4A3;EIF4G2;ELAVL1;ELAVL3;EWSR1;FAM120A;FBL;FMR1;FUS;FXR1;FXR2;GNL3;GTF2F1;HNRNPA1;HNRNPA2B1;HNRNPC;HNRNPU;HNRNPUL1;IGF2BP1;IGF2BP2;IGF2BP3;KHDRBS1;KHDRBS2;KHSRP;LARP7;LIN28;LIN28B;LSM11;MOV10;MSI2;NONO;NOP56;NOP58;NUMA1;PRPF8;PTBP1;RBFOX2;RBM10;RBM27;SAFB2;SBDS;SLTM;SMNDC1;SND1;SRSF1;SRSF3;SRSF7;SRSF9;TAF15;TARDBP;TIA1;TIAL1;TNRC6A;TRA2A;TROVE2;U2AF1;U2AF2;UPF1;XRN2;YWHAG;ZNF184NA
chr12:53174012-53174827:-
THYMEERESENSG00000151657.7chr107780263:7780307:7783080:7783175:7787819:7787981-0.34104.9596e-027.0664e-05-0.4220imageNNNAT_cells_CD4_naiveGSVA_HALLMARK_APICAL_SURFACE
ENSG00000139631.17,CSAD
THYMEAGESENSG00000122490.14chr1879904140:79904183:79933968:79934022:79943328:799434620.39091.8458e-025.3810e-050.4235imageNADAR;AIFM1;BCCIP;BUD13;CELF2;CNBP;CPSF6;CSTF2T;DDX3X;DDX42;DDX54;DGCR8;DHX9;DICER1;DKC1;EIF4A3;EIF4G2;ELAVL1;ELAVL3;EWSR1;FAM120A;FBL;FKBP4;FMR1;FUS;FXR1;FXR2;GTF2F1;HNRNPA1;HNRNPA2B1;HNRNPC;HNRNPD;HNRNPK;HNRNPL;HNRNPM;HNRNPU;HNRNPUL1;IGF2BP1;IGF2BP2;IGF2BP3;ILF3;KHDRBS1;KHDRBS2;KHSRP;LIN28;LIN28B;MOV10;MSI1;NOP56;NOP58;NPM1;NUMA1;PCBP2;PRPF8;PTBP1;RANGAP1;RBFOX2;RBM10;RBM22;RBM27;SAFB2;SF3A3;SF3B4;SLTM;SMNDC1;SND1;SRSF1;SRSF3;SRSF7;SRSF9;TAF15;TARDBP;TIA1;TIAL1;TNRC6A;TRA2A;TROVE2;U2AF1;U2AF2;UPF1;XRN2;YTHDC1;YTHDF1;YWHAG;ZNF184NAMacrophages_M1GSVA_HALLMARK_ESTROGEN_RESPONSE_EARLY
ENSG00000139631.17,CSAD
THYMEAGA3ENSG00000187609.11chr9137323724:137323856:137309590:137309790:137309590:1373097000.27434.4384e-024.8399e-040.4090imageNACIN1;ADAR;AIFM1;AUH;BCCIP;BUD13;CNBP;CPSF6;CSTF2T;DDX3X;DDX42;DDX54;DGCR8;DHX9;DKC1;EIF4A3;EIF4G2;ELAVL1;ELAVL3;EWSR1;FAM120A;FBL;FKBP4;FMR1;FUS;FXR1;FXR2;GNL3;GTF2F1;HNRNPA1;HNRNPA2B1;HNRNPC;HNRNPD;HNRNPK;HNRNPL;HNRNPM;HNRNPU;HNRNPUL1;IGF2BP1;IGF2BP2;IGF2BP3;ILF3;KHDRBS1;KHSRP;LIN28;LIN28B;LSM11;MOV10;MSI1;MSI2;NONO;NOP56;NOP58;PCBP2;PRPF8;PTBP1;RBFOX2;RBM10;RBM22;RBM27;RNF219;SAFB2;SF3A3;SF3B4;SLBP;SLTM;SMNDC1;SND1;SRSF1;SRSF3;SRSF7;SRSF9;TAF15;TARDBP;TIA1;TNRC6A;TRA2A;TROVE2;U2AF1;U2AF2;UPF1;VIM;XRN2;YTHDF1;YWHAG;ZNF184NAT_cells_CD4_naive
chr12:53174012-53174827:-
THYMEERESENSG00000203705.6chr1212804618:212804651:212807735:212807848:212812250:212812328-0.34931.1569e-021.9661e-04-0.4023imageNNNAGSVA_HALLMARK_UNFOLDED_PROTEIN_RESPONSE
ENSG00000139631.17,CSAD
THYMEAGMEXENSG00000119013.4chr2201072029:201072059:201072338:201072361:201073119:201073153:201078880:2010790220.38851.8527e-026.1292e-050.4206imageNAIFM1;AUH;BUD13;CNBP;CPSF6;CSTF2T;DDX3X;DDX42;DDX54;DGCR8;DHX9;EIF4A3;EIF4G2;ELAVL1;ELAVL3;EWSR1;FAM120A;FBL;FMR1;FUS;FXR1;FXR2;GNL3;GTF2F1;HNRNPA1;HNRNPA2B1;HNRNPC;HNRNPU;HNRNPUL1;IGF2BP1;IGF2BP2;IGF2BP3;KHDRBS1;KHDRBS2;KHSRP;LARP7;LIN28;LIN28B;LSM11;MOV10;MSI2;NONO;NOP56;NOP58;NUMA1;PRPF8;PTBP1;RBFOX2;RBM10;RBM27;SAFB2;SBDS;SLTM;SMNDC1;SND1;SRSF1;SRSF3;SRSF7;SRSF9;TAF15;TARDBP;TIA1;TIAL1;TNRC6A;TRA2A;TROVE2;U2AF1;U2AF2;UPF1;XRN2;YWHAG;ZNF184NA

More results



Top

5. Enriched editing regions and immune infiltration for CSAD


all structure

check button Associations of enriched editing regions with immune infiltration.
* P<0.05 and Informative number >=20.
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of EERs/EAGs with the fraction of different immune cells according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerTypeIDImmuneCellPRCorrelationPlot
ENSG00000139631.17,CSADACCEAGT_cells_CD4_memory_resting4.3602e-030.4172image
chr12:53174012-53174827:-BLCAEERMast_cells_resting1.0252e-020.2031image
ENSG00000139631.17,CSADBLCAEAGEosinophils2.5606e-020.1712image
chr12:53174012-53174827:-BRCAEERMast_cells_resting1.0081e-02-0.0971image
chr12:53176125-53179181:-BRCAEERT_cells_regulatory_(Tregs)4.1930e-020.0772image
ENSG00000139631.17,CSADBRCAEAGNK_cells_activated8.4895e-03-0.0935image
chr12:53176125-53179181:-CESCEERB_cells_naive1.8943e-020.2072image
ENSG00000139631.17,CSADCESCEAGT_cells_CD4_naive3.2791e-050.2942image
ENSG00000139631.17,CSADCHOLEAGT_cells_regulatory_(Tregs)2.4039e-02-0.4254image
ENSG00000139631.17,CSADESCAEAGMacrophages_M02.2499e-02-0.1935image
chr12:53174012-53174827:-GBMEERMacrophages_M02.1571e-020.2520image
chr12:53176125-53179181:-GBMEERDendritic_cells_activated2.8313e-020.2622image
chr12:53176125-53179181:-HNSCEERMacrophages_M25.7349e-030.3711image
ENSG00000139631.17,CSADHNSCEAGMacrophages_M23.7642e-030.2961image
chr12:53174012-53174827:-KICHEERNK_cells_activated1.7579e-020.4706image
chr12:53176125-53179181:-KICHEERB_cells_memory1.8718e-040.6795image
chr12:53174012-53174827:-KIRCEERT_cells_CD4_memory_resting2.0980e-03-0.2343image
ENSG00000139631.17,CSADKIRPEAGMast_cells_resting4.1127e-020.1704image
chr12:53176125-53179181:-LAMLEERMast_cells_resting1.6309e-030.3919image
ENSG00000139631.17,CSADLAMLEAGMast_cells_resting3.9400e-030.2765image
chr12:53176125-53179181:-LGGEERMacrophages_M13.0983e-02-0.1376image
ENSG00000139631.17,CSADLGGEAGMacrophages_M12.3866e-02-0.1222image
chr12:53176125-53179181:-LIHCEERMast_cells_activated5.4922e-040.4472image
ENSG00000139631.17,CSADLIHCEAGEosinophils2.9198e-030.2717image
chr12:53174012-53174827:-LUADEERMast_cells_resting1.2417e-02-0.1801image
chr12:53176125-53179181:-LUADEERT_cells_CD4_memory_activated1.2297e-020.1884image
ENSG00000139631.17,CSADLUADEAGT_cells_CD4_memory_activated8.4664e-030.1721image
chr12:53174012-53174827:-LUSCEERMacrophages_M23.9039e-030.1960image
chr12:53176125-53179181:-LUSCEERMacrophages_M17.6372e-03-0.1886image
ENSG00000139631.17,CSADLUSCEAGMacrophages_M22.9902e-030.1852image
chr12:53176125-53179181:-MESOEERDendritic_cells_resting1.8775e-020.4264image
ENSG00000139631.17,CSADMESOEAGT_cells_follicular_helper2.6597e-020.3342image
chr12:53174012-53174827:-OVEERPlasma_cells6.5155e-030.1868image
chr12:53176125-53179181:-OVEERMacrophages_M02.7249e-020.1735image
ENSG00000139631.17,CSADOVEAGT_cells_CD4_memory_activated1.0539e-02-0.1710image
ENSG00000139631.17,CSADPAADEAGMacrophages_M13.3238e-020.2399image
chr12:53174012-53174827:-PCPGEERDendritic_cells_resting4.9208e-030.4360image
chr12:53176125-53179181:-PCPGEERDendritic_cells_resting9.6189e-030.4807image
ENSG00000139631.17,CSADPCPGEAGDendritic_cells_resting8.9678e-030.3696image
chr12:53174012-53174827:-PRADEERT_cells_follicular_helper2.1497e-02-0.1423image
chr12:53176125-53179181:-PRADEERMacrophages_M22.3320e-02-0.1569image
ENSG00000139631.17,CSADPRADEAGT_cells_CD4_memory_resting1.5205e-020.1412image
chr12:53176125-53179181:-SARCEERB_cells_naive2.0208e-020.3343image
ENSG00000139631.17,CSADSARCEAGMast_cells_resting5.1057e-040.3571image
chr12:53174012-53174827:-SKCMEERT_cells_CD86.7581e-03-0.2534image
chr12:53176125-53179181:-SKCMEERT_cells_regulatory_(Tregs)8.8857e-03-0.2743image
ENSG00000139631.17,CSADSKCMEAGMacrophages_M22.0356e-020.2002image
chr12:53174012-53174827:-STADEERMacrophages_M14.6566e-020.1343image
chr12:53176125-53179181:-STADEERT_cells_CD4_memory_resting2.1547e-02-0.1805image
chr12:53176125-53179181:-TGCTEERT_cells_CD4_memory_activated3.7617e-030.5683image
ENSG00000139631.17,CSADTGCTEAGNeutrophils1.8025e-020.3677image
chr12:53174012-53174827:-THCAEERDendritic_cells_activated1.0520e-030.1983image
chr12:53176125-53179181:-THCAEERNK_cells_resting3.4642e-02-0.1419image
chr12:53174012-53174827:-THYMEERPlasma_cells4.3371e-02-0.2159image
ENSG00000139631.17,CSADTHYMEAGMast_cells_resting1.0310e-020.2706image
chr12:53176125-53179181:-UCECEERDendritic_cells_activated1.3918e-030.4940image
ENSG00000139631.17,CSADUCECEAGPlasma_cells1.3125e-02-0.2780image
chr12:53174012-53174827:-UCSEERT_cells_CD4_memory_resting3.3866e-020.3822image
ENSG00000139631.17,CSADUCSEAGT_cells_CD4_memory_resting3.0701e-020.3887image
ENSG00000139631.17,CSADUVMEAGT_cells_follicular_helper4.4643e-02-0.4134image


Top

6. Enriched editing regions and immune gene sets for CSAD


all structure

check button Correlation of enriched editing regions with epithelial-mesenchymal transition.
* First, the differences of enriched editing regions between Epi and Mes groups (defined by KS-test) were compared (P<0.05 and Informative number >=20).
* Second, the correlations between enriched editing regions and gene set score of HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION were analyzed (P<0.05 and Informative number >=20).
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the EERs/EAGs significantly edited between Epi and Mes group.
ID_eventscancerTypeE2M_PBoxplotCorPCorRCorrelationPlot


Top

check button Correlations of enriched editing regions with hypoxic.
* First, there are four hypoxia scores used in the database. The first three hypoxic scores were calculated on three gene sets of Buffa, Ragnum and Winter based on one previous study (PMID: 32024819). One last hypoxia score was defined on HALLMARK_HYPOXIA by GSVA method.
* Second, the correlations enriched editing regions with the four hypoxic scores were analyzed (P<0.05 and Informative number >=20).
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the EERs/EAGs significantly correlated with all four hypoxia gene set scores. For more results, please go to download page.
ID_eventscancerTypeBuffa_P Buffa_R Ragnum_P Ragnum_R Winter_P Winter_R HALLMARK_P HALLMARK_R CorrelationPlot
chr12:53176125-53179181:-KIRPEER3.6474e-020.20444.4984e-020.19613.1927e-020.20952.7159e-020.2156image
chr12:53174012-53174827:-LUADEER9.2586e-030.18741.8076e-020.17058.0627e-030.19072.8733e-030.2140image


Top

check button Associations of enriched editing regions with hallmark gene sets from MSigDB.
* P<0.05 and Informative number >=20.
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of EERs/EAGs with the scores of 50 hallmark genesets according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerHallmarkTypeTypePRCorrelationPlot
chr12:53176125-53179181:-ACCGSVA_HALLMARK_P53_PATHWAYEER1.9953e-020.5157image
chr12:53176125-53179181:-BLCAGSVA_HALLMARK_MYC_TARGETS_V2EER2.7573e-020.2249image
chr12:53174012-53174827:-BLCAGSVA_HALLMARK_NOTCH_SIGNALINGEER8.5464e-060.3448image
ENSG00000139631.17,CSADBLCAGSVA_HALLMARK_NOTCH_SIGNALINGEAG5.3877e-040.2627image
chr12:53174012-53174827:-BRCAGSVA_HALLMARK_PANCREAS_BETA_CELLSEER9.0722e-080.2000image
chr12:53176125-53179181:-BRCAGSVA_HALLMARK_GLYCOLYSISEER2.5534e-050.1590image
ENSG00000139631.17,CSADBRCAGSVA_HALLMARK_ANDROGEN_RESPONSEEAG6.6261e-080.1905image
ENSG00000139631.17,CSADCESCGSVA_HALLMARK_MYC_TARGETS_V1EAG4.0612e-03-0.2059image
chr12:53174012-53174827:-CESCGSVA_HALLMARK_UV_RESPONSE_UPEER4.7752e-030.2083image
ENSG00000139631.17,CSADCHOLGSVA_HALLMARK_HEME_METABOLISMEAG2.4788e-020.4233image
ENSG00000139631.17,CSADESCAGSVA_HALLMARK_WNT_BETA_CATENIN_SIGNALINGEAG1.4209e-02-0.2076image
chr12:53176125-53179181:-ESCAGSVA_HALLMARK_KRAS_SIGNALING_UPEER9.5080e-030.2485image
chr12:53174012-53174827:-GBMGSVA_HALLMARK_HEME_METABOLISMEER4.0582e-030.3122image
chr12:53176125-53179181:-GBMGSVA_HALLMARK_PEROXISOMEEER8.2075e-030.3136image
chr12:53176125-53179181:-HNSCGSVA_HALLMARK_MITOTIC_SPINDLEEER4.0963e-020.2791image
ENSG00000139631.17,CSADHNSCGSVA_HALLMARK_MITOTIC_SPINDLEEAG2.5073e-040.3692image
ENSG00000139631.17,CSADKICHGSVA_HALLMARK_OXIDATIVE_PHOSPHORYLATIONEAG1.1456e-020.4348image
chr12:53176125-53179181:-KICHGSVA_HALLMARK_WNT_BETA_CATENIN_SIGNALINGEER3.8025e-02-0.4171image
chr12:53174012-53174827:-KICHGSVA_HALLMARK_OXIDATIVE_PHOSPHORYLATIONEER1.5416e-020.4790image
chr12:53174012-53174827:-KIRCGSVA_HALLMARK_FATTY_ACID_METABOLISMEER2.3243e-040.2788image
ENSG00000139631.17,CSADKIRCGSVA_HALLMARK_PANCREAS_BETA_CELLSEAG2.6404e-020.1619image
chr12:53176125-53179181:-KIRPGSVA_HALLMARK_COAGULATIONEER3.5049e-030.2825image
ENSG00000139631.17,CSADKIRPGSVA_HALLMARK_DNA_REPAIREAG2.6162e-02-0.1853image
chr12:53176125-53179181:-LAMLGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEER1.3618e-02-0.3118image
ENSG00000139631.17,CSADLAMLGSVA_HALLMARK_MYC_TARGETS_V1EAG5.8085e-030.2650image
ENSG00000139631.17,CSADLGGGSVA_HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAYEAG2.7738e-02-0.1190image
chr12:53174012-53174827:-LGGGSVA_HALLMARK_OXIDATIVE_PHOSPHORYLATIONEER7.8001e-040.1890image
ENSG00000139631.17,CSADLIHCGSVA_HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAYEAG2.2924e-030.2781image
chr12:53174012-53174827:-LUADGSVA_HALLMARK_ESTROGEN_RESPONSE_LATEEER3.1202e-040.2575image
chr12:53176125-53179181:-LUADGSVA_HALLMARK_NOTCH_SIGNALINGEER2.1300e-02-0.1735image
ENSG00000139631.17,CSADLUADGSVA_HALLMARK_ANDROGEN_RESPONSEEAG1.2950e-020.1626image
chr12:53176125-53179181:-LUSCGSVA_HALLMARK_HEME_METABOLISMEER1.4024e-020.1739image
chr12:53174012-53174827:-LUSCGSVA_HALLMARK_MITOTIC_SPINDLEEER5.9008e-03-0.1872image
ENSG00000139631.17,CSADLUSCGSVA_HALLMARK_HEME_METABOLISMEAG1.9594e-020.1461image
ENSG00000139631.17,CSADMESOGSVA_HALLMARK_MYC_TARGETS_V2EAG1.2909e-020.3720image
ENSG00000139631.17,CSADOVGSVA_HALLMARK_OXIDATIVE_PHOSPHORYLATIONEAG7.7149e-030.1780image
chr12:53174012-53174827:-OVGSVA_HALLMARK_OXIDATIVE_PHOSPHORYLATIONEER1.3298e-050.2949image
ENSG00000139631.17,CSADPAADGSVA_HALLMARK_PROTEIN_SECRETIONEAG4.9676e-020.2216image
ENSG00000139631.17,CSADPCPGGSVA_HALLMARK_SPERMATOGENESISEAG4.9168e-030.3955image
chr12:53176125-53179181:-PCPGGSVA_HALLMARK_APOPTOSISEER3.5625e-02-0.3986image
chr12:53174012-53174827:-PCPGGSVA_HALLMARK_PEROXISOMEEER8.4566e-050.5810image
ENSG00000139631.17,CSADPRADGSVA_HALLMARK_UV_RESPONSE_DNEAG2.7696e-040.2102image
chr12:53176125-53179181:-PRADGSVA_HALLMARK_DNA_REPAIREER2.1426e-02-0.1591image
chr12:53174012-53174827:-PRADGSVA_HALLMARK_ADIPOGENESISEER7.6322e-030.1648image
chr12:53174012-53174827:-SARCGSVA_HALLMARK_KRAS_SIGNALING_DNEER3.4776e-02-0.2442image
ENSG00000139631.17,CSADSARCGSVA_HALLMARK_GLYCOLYSISEAG1.4093e-03-0.3298image
chr12:53176125-53179181:-SKCMGSVA_HALLMARK_HEDGEHOG_SIGNALINGEER3.5042e-020.2225image
ENSG00000139631.17,CSADSTADGSVA_HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAYEAG3.1799e-040.2324image
chr12:53174012-53174827:-STADGSVA_HALLMARK_P53_PATHWAYEER4.9468e-050.2700image
ENSG00000139631.17,CSADTGCTGSVA_HALLMARK_FATTY_ACID_METABOLISMEAG2.7576e-04-0.5391image
chr12:53176125-53179181:-TGCTGSVA_HALLMARK_MTORC1_SIGNALINGEER1.5386e-020.4887image
chr12:53176125-53179181:-THCAGSVA_HALLMARK_APOPTOSISEER1.0657e-020.1711image
chr12:53174012-53174827:-THCAGSVA_HALLMARK_ESTROGEN_RESPONSE_EARLYEER1.9414e-040.2249image
ENSG00000139631.17,CSADTHCAGSVA_HALLMARK_TGF_BETA_SIGNALINGEAG2.0304e-030.1760image
ENSG00000139631.17,CSADTHYMGSVA_HALLMARK_ESTROGEN_RESPONSE_LATEEAG1.0983e-020.2684image
chr12:53174012-53174827:-THYMGSVA_HALLMARK_ESTROGEN_RESPONSE_LATEEER2.9954e-020.2316image
ENSG00000139631.17,CSADUVMGSVA_HALLMARK_HEME_METABOLISMEAG9.5721e-030.5177image


Top

7. Enriched editing regions and drugs for CSAD


all structure

check button Correlations between enriched editing regions and drug sensitivity.
* First, the drug sensitivity (IS50) was estimated on 84 drugs by pRRophetic package.
* Second, the correlations between editing enriched regions and drug sensitivity were analyzed (P<0.05 and Informative number >=20).
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of EERs/EAGs with the IS50 scores of 84 drugs according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerDrugTypePRCorrelationPlot
chr12:53176125-53179181:-ACCBMS.754807EER2.0306e-020.5144image
ENSG00000139631.17,CSADACCBAY.61.3606EAG2.5508e-020.3328image
chr12:53174012-53174827:-ACCBAY.61.3606EER3.7889e-020.3140image
chr12:53174012-53174827:-BLCAJNJ.26854165EER3.8406e-03-0.2280image
ENSG00000139631.17,CSADBRCABMS.708163EAG2.1644e-04-0.1312image
chr12:53176125-53179181:-BRCACCT007093EER3.6396e-060.1746image
chr12:53174012-53174827:-BRCAFTI.277EER5.7484e-040.1296image
chr12:53176125-53179181:-CESCIPA.3EER5.1098e-030.2461image
ENSG00000139631.17,CSADCESCBMS.754807EAG7.7038e-030.1913image
chr12:53174012-53174827:-CESCAS601245EER4.2989e-02-0.1502image
ENSG00000139631.17,CSADCHOLEmbelinEAG1.4491e-02-0.4570image
ENSG00000139631.17,CSADCOADCI.1040EAG7.0835e-030.3106image
chr12:53176125-53179181:-COADCI.1040EER8.0556e-030.3743image
chr12:53176125-53179181:-ESCACMKEER1.7708e-020.2278image
ENSG00000139631.17,CSADESCACI.1040EAG1.0288e-03-0.2755image
ENSG00000139631.17,CSADGBMFH535EAG4.5761e-020.2055image
chr12:53176125-53179181:-GBMKU.55933EER1.0804e-02-0.3029image
chr12:53174012-53174827:-GBMKIN001.135EER2.4036e-03-0.3288image
ENSG00000139631.17,CSADHNSCBMS.509744EAG1.7759e-040.3773image
chr12:53176125-53179181:-HNSCBI.D1870EER2.9271e-020.2969image
chr12:53176125-53179181:-KICHGW.441756EER1.4316e-020.4836image
chr12:53174012-53174827:-KICHGW.441756EER3.4356e-02-0.4246image
ENSG00000139631.17,CSADKICHCEP.701EAG5.2567e-030.4746image
chr12:53176125-53179181:-KIRCMidostaurinEER8.8913e-03-0.2069image
ENSG00000139631.17,CSADKIRCEpothilone.BEAG2.6521e-02-0.1618image
chr12:53174012-53174827:-KIRCAZD6482EER1.9466e-030.2367image
chr12:53176125-53179181:-KIRPAICAREER3.9231e-02-0.2016image
ENSG00000139631.17,CSADKIRPEmbelinEAG9.7253e-03-0.2148image
chr12:53176125-53179181:-LAMLBI.D1870EER4.2468e-03-0.3583image
ENSG00000139631.17,CSADLAMLDocetaxelEAG2.9452e-03-0.2848image
ENSG00000139631.17,CSADLGGBryostatin.1EAG2.1788e-020.1240image
chr12:53174012-53174827:-LGGABT.888EER1.6805e-040.2111image
ENSG00000139631.17,CSADLIHCGSK.650394EAG1.9556e-030.2823image
chr12:53176125-53179181:-LIHCBI.2536EER2.5397e-030.3957image
chr12:53174012-53174827:-LUADMG.132EER1.8443e-02-0.1699image
chr12:53176125-53179181:-LUADBMS.708163EER1.1839e-03-0.2425image
ENSG00000139631.17,CSADLUADEpothilone.BEAG2.8017e-03-0.1950image
chr12:53176125-53179181:-LUSCCisplatinEER9.4230e-030.1836image
chr12:53174012-53174827:-LUSCMG.132EER4.7869e-04-0.2367image
ENSG00000139631.17,CSADLUSCCamptothecinEAG3.6024e-020.1314image
ENSG00000139631.17,CSADMESOBryostatin.1EAG1.6675e-020.3591image
chr12:53176125-53179181:-OVAKT.inhibitor.VIIIEER1.1221e-020.1988image
ENSG00000139631.17,CSADOVMG.132EAG1.5955e-03-0.2107image
chr12:53174012-53174827:-OVMG.132EER1.6660e-05-0.2923image
chr12:53176125-53179181:-PAADEHT.1864EER6.0323e-030.3989image
ENSG00000139631.17,CSADPAADBI.D1870EAG1.3792e-020.2778image
chr12:53174012-53174827:-PCPGCamptothecinEER9.1331e-030.4071image
ENSG00000139631.17,CSADPCPGAZD.0530EAG5.7613e-040.4743image
chr12:53176125-53179181:-PCPGDasatinibEER4.5995e-030.5196image
ENSG00000139631.17,CSADPRADBMS.509744EAG4.0709e-030.1668image
chr12:53176125-53179181:-PRADBX.795EER1.8865e-02-0.1623image
chr12:53174012-53174827:-PRADBIRB.0796EER2.9616e-020.1347image
chr12:53176125-53179181:-SARCAZD6244EER2.6910e-030.4237image
ENSG00000139631.17,CSADSARCCEP.701EAG1.3303e-040.3899image
chr12:53174012-53174827:-SARCCGP.082996EER6.3265e-03-0.3126image
chr12:53176125-53179181:-SKCMBicalutamideEER3.0726e-02-0.2279image
ENSG00000139631.17,CSADSKCMCCT018159EAG1.1122e-020.2187image
ENSG00000139631.17,CSADSTADA.443654EAG8.8543e-03-0.1701image
chr12:53176125-53179181:-STADA.443654EER7.3363e-03-0.2099image
chr12:53174012-53174827:-STADABT.263EER1.3588e-020.1662image
chr12:53176125-53179181:-TGCTGefitinibEER2.2239e-02-0.4644image
ENSG00000139631.17,CSADTGCTErlotinibEAG1.6689e-020.3718image
chr12:53176125-53179181:-THCADasatinibEER9.3287e-04-0.2207image
ENSG00000139631.17,CSADTHCAAMG.706EAG7.6425e-040.1917image
chr12:53174012-53174827:-THCAAMG.706EER7.4743e-050.2386image
ENSG00000139631.17,CSADTHYMGDC0941EAG1.9023e-030.3248image
ENSG00000139631.17,CSADUCECCisplatinEAG3.3451e-02-0.2396image
chr12:53176125-53179181:-UCECCisplatinEER2.8190e-02-0.3516image
chr12:53174012-53174827:-UCSBX.795EER2.6710e-040.6102image
ENSG00000139631.17,CSADUCSBX.795EAG4.4033e-040.5929image


Top

check button EAGs targeted by drugs from DrugBank database.
* EAG: EER-associated genes.
EERENSTUniprotIDDrugBankIDDrugDrugType
chr12:53174012-53174827:-ENST00000267085.7Q9Y600DB00114Pyridoxal phosphateSmallMoleculeDrug
chr12:53174012-53174827:-ENST00000267085.7Q9Y600DB00151CysteineSmallMoleculeDrug
chr12:53174012-53174827:-ENST00000379846.4Q9Y600DB00114Pyridoxal phosphateSmallMoleculeDrug
chr12:53174012-53174827:-ENST00000379846.4Q9Y600DB00151CysteineSmallMoleculeDrug
chr12:53174012-53174827:-ENST00000444623.4Q9Y600DB00114Pyridoxal phosphateSmallMoleculeDrug
chr12:53174012-53174827:-ENST00000444623.4Q9Y600DB00151CysteineSmallMoleculeDrug
chr12:53174012-53174827:-ENST00000453446.5Q9Y600DB00114Pyridoxal phosphateSmallMoleculeDrug
chr12:53174012-53174827:-ENST00000453446.5Q9Y600DB00151CysteineSmallMoleculeDrug
chr12:53176125-53179181:-ENST00000379846.4Q9Y600DB00114Pyridoxal phosphateSmallMoleculeDrug
chr12:53176125-53179181:-ENST00000379846.4Q9Y600DB00151CysteineSmallMoleculeDrug
chr12:53176125-53179181:-ENST00000444623.4Q9Y600DB00114Pyridoxal phosphateSmallMoleculeDrug
chr12:53176125-53179181:-ENST00000444623.4Q9Y600DB00151CysteineSmallMoleculeDrug